From NASH to HCC: current concepts and future challenges

QM Anstee, HL Reeves, E Kotsiliti, O Govaere… - Nature reviews …, 2019 - nature.com
Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

JL Raoul, A Forner, L Bolondi, TT Cheung… - Cancer treatment …, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the
sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient …

[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Gut and liver, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] Development of a new nomogram including neutrophil-to-lymphocyte ratio to predict survival in patients with hepatocellular carcinoma undergoing …

YE Chon, H Park, HK Hyun, Y Ha, MN Kim, BK Kim… - Cancers, 2019 - mdpi.com
The neutrophil-to-lymphocyte ratio (NLR) has recently been reported to predict the
prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the …

Nomogram and artificial neural network for prognostic performance on the albumin-bilirubin grade for hepatocellular carcinoma undergoing transarterial …

BY Zhong, CF Ni, JS Ji, GW Yin, L Chen, HD Zhu… - Journal of Vascular and …, 2019 - Elsevier
Purpose To construct the albumin-bilirubin (ALBI) grade and the Child-Turcotte-Pugh (CTP)
score based on nomograms, as well as to develop an artificial neural network (ANN) to …

Intermediate stage hepatocellular carcinoma: a summary review

O Elshaarawy, A Gomaa, H Omar… - Journal of …, 2019 - Taylor & Francis
It is well known that intermediate stage hepatocellular carcinoma (HCC) encompasses the
widest class of patients with this disease. The main characteristic of this special sub-group of …

Short-and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma

B Scheiner, G Ulbrich, M Mandorfer… - United European …, 2019 - journals.sagepub.com
Background Transarterial chemoembolization (TACE) affects hepatic perfusion, and might
have an impact on portal pressure in patients with hepatocellular carcinoma (HCC) …

Transarterial chemoembolization combined with radiofrequency ablation in the treatment of stage B1 intermediate hepatocellular carcinoma

F Liu, M Chen, J Mei, L Xu, R Guo, X Lin… - Journal of …, 2019 - Wiley Online Library
Background. Due to the heterogeneity of patients with Barcelona clinic liver cancer (BCLC)
intermediate‐stage hepatocellular carcinoma (HCC), Bolondi criteria were proposed and …

[HTML][HTML] Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization

J Delicque, M Hermida, L Piron, C Allimant… - Diagnostic and …, 2019 - Elsevier
Purpose The purpose of this study was to assess liver function deterioration, as assessed
using the model for end-stage liver disease (MELD) score variations, following transarterial …